LICENSE DETAILS RELATED VIDEOS KEYWORDS © Chris Tefme Video of medical syringe and red drug By Chris Tefme for Dissolve Auteur™ Stock Footage ID: D2492_3_007 Clip length: 00:42 Release: No releases Frame rate: 29.97 fps License: Royalty-free license Original codec: M-JPEG Choose a size 1920 x 1080 ProRes and H.264 $29 3840 x 2160 M-JPEG and H.264 $49 Choose a royalty-free license What license do I need? What license do I need? Commercial royalty-free license options Royalty-free clips marked “Released” and “No release required” may be used in an unlimited number of commercial or editorial projects, worldwide, in perpetuity, in accordance with this table. Standard Included Plus $49 Extended $99 Users 1 Unlimited, assign license to client Unlimited, assign license to client Medium Social/web use Social/web use, internal corporate, and regional advertising National advertising and film/TV shows Indemnification Up to 10x purchase price Up to 10x purchase price Up to $100K Select Select Select View full licensing details on dissolve.com/licensing Standard Included A single user Social/web use Indemnification: Up to 10x purchase price Plus $49 Unlimited users, assign license to client Social/web use, internal corporate, and regional advertising Indemnification: Up to 10x purchase price Extended $99 Unlimited users, assign license to client Plus mediums, national advertising, and film/TV shows Unlimited number of digital or print products for resale Indemnification: Up to $100K License Add-ons Tv/Film Add-on $99 Tv/Film includes the injunctive relief clause which omits Dissolve's right to enjoin production. Learn more From $29 USD Add to cart Market freeze Need this item exclusively? We'll provide a license for as long as you need. Request a quote Buy more and save Qualify for discounts when you purchase $500 or more. See details Save to folder Download comp Market freeze Email First Name Last Name How long do you need exclusivity? When do you need exclusivity by? What is your budget? Tell us more about your project Submit Cancel Thanks, We'll get back to you ASAP If you have any questions, please contact us Return to licensing